By Daniel Siegal ( June 28, 2019, 10:36 PM EDT) -- A former medical director at Johnson & Johnson subsidiary Janssen Pharmaceuticals on Friday defended the company's marketing of opioids as having a low risk of addiction during cross-examination by an attorney for Oklahoma, which is seeking to hold the drugmakers liable for the opioid crisis....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.